Skip to main content
Log in

Tumour induction as a consequence of immunosuppression after renal transplantation

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Immunosuppressed recipients of organ transplants have a higher incidence of carcinoma than the general population. A retrospective analysis was made at the Department of Urology of Bonn University, investigating 236 renal allograft recipients as to the incidence of neoplasms before and after transplantation. Eleven patients developed malignant tumours after transplantation. In 4 out of these 11 patients, case history showed pre-existing malignancies. Two of the 4 patients developed a second tumour, while the other two had tumour progression (latency period 21–77 months). Three of the 4 patients died of their tumours 21, 42 and 77 months after transplantation, whereas one female patient is still alive and free of neoplasms 32 months after transplantation. In 7 out of these 11 patientsde novo tumours were diagnosed (latency period 3–88 months). All of them are still alive (NED between 15 and 85 months), six of them with good transplant function. There was no difference to be seen in the incidence of malignancies between kidneys supplied by Eurotransplant (n=40) and ABO compatible kidneys from our own donors (n=196). The higher incidence rate of neoplasms in transplant recipients requires high standards in preventive measures. Any suspicious change that may occur in the course of a thorough follow-up of transplant recipients must be removed and examined histologically. Patients with previous malignant diseases must be payed special attention, since they frequently tend to develop another malignant tumour and progression of existing tumours, respectively.

As far as immunosuppression is concerned, therapeutic guidelines for the treatment of transplant recipients do not differ from those set up for patients on haemodialysis. Since immunosuppression with increased rates of tumour incidence can also be observed in dialysis patients, the mere fact of increased incidence of neoplasms cannot be taken as an argument against transplantation. With a more or less equal risk of tumour incidence the crucial factor should be the higher quality of life for transplant recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blohme, I., Brynger, H.: Malignant disease in renal transplant patients.Transplantation, 39, 23 (1985).

    PubMed  CAS  Google Scholar 

  2. Kinlen, L. J., Eastwood, J. B., Kerr, D. N. S., Moorhead, J. F., Oliver, D. O., Robinson, B. H. B., De Wardener, H. E., Wing, A. J.: Cancer in patients receiving dialysis.Br. Med. J., 1, 1401 (1980).

    Google Scholar 

  3. Penn, I.: Development of cancer as a complication of clinical transplantation.Transplant. Proc., 9, 1121 (1977).

    PubMed  CAS  Google Scholar 

  4. Penn, I.: The occurrence of cancer in immune deficiencies.Curr. Probl. Cancer, 6 (10). 1 (1982).

    Article  PubMed  CAS  Google Scholar 

  5. Sheil, A. G. R.: Cancer after transplantation.World J. Surg., 10, 389 (1986).

    Article  PubMed  CAS  Google Scholar 

  6. Jacobs, C., Brunner, F. P., Brynger, H., Chantler, C., Donckerwolcke, R. A., Hathaway, R. A., Kramer, P., Selwood, N. H., Wing, A. J.: Malignant disease in patients treated by dialysis and transplantation in Europe.Transplant. Proc., 13, 729 (1981).

    PubMed  CAS  Google Scholar 

  7. Sheil, A. G. R., Mahoney, J. F., Horvarth, J. S., Johnson, J. R., Tiller, D. J., Steward, J. H.: Cancer and survival after cadaveric donor renal transplantation.Transplant. Proc., 11, 1052 (1979).

    PubMed  CAS  Google Scholar 

  8. Noronha, I. L., Ritz, E., Waldherr, R., Stein, G., Fassbinder, W.: Renal cell carcinoma in dialysis patients with acquired renal cysts.Nephrol. Dial. Transplant., 4, 763 (1989).

    PubMed  CAS  Google Scholar 

  9. Sutherland, G. A., Glass, J., Gabriel, R.: Increased incidence of malignancy in chronic renal failure.Nephron, 18, 182 (1977).

    PubMed  CAS  Google Scholar 

  10. Martin, D. C., Rubini, M., Rosen, V. J.: Cadaveric renal homotransplantation with inadvertent transplantation of carcinoma.JAMA, 192, 82 (1965).

    Google Scholar 

  11. McPhaul, J. J., McIntosh, D. A.: Tissue transplantation still vexes.N. Engl. J. Med., 272, 105 (1965).

    Google Scholar 

  12. Wilson, R. E., Hager, E. B., Hampers, C. L., Corsons, J. M., Merrill, J. P., Murray, J. E.: Immunologic rejection of human cancer transplanted with renal allograft.N. Engl. J. Med., 278, 479 (1968).

    Article  PubMed  CAS  Google Scholar 

  13. Zukowski, C. F., Killen, D. A., Ginn, E., Matter, B., Lucas, D. O., Seigler, H. F.: Transplanted carcinoma in an immunosuppressed patient.Transplantation, 9, 71 (1970).

    Article  Google Scholar 

  14. Lindner, A., Farewell, V. T., Sherrard, D. J.: High incidence of neoplasia in uremic patients receiving long-term dialysis.Nephron, 27, 292 (1981).

    PubMed  CAS  Google Scholar 

  15. Digenis, G., Pierratos, A., Oreopoulos, D. G.: Cancer and chronic renal failure.CMAJ, 135, 14 (1986).

    PubMed  CAS  Google Scholar 

  16. Planz, B., Gladziwa, U., Sohn, M., Jakse, G.: Urologische Tumoren bei Patienten mit Niereninsuffizienz.Urologe [B],34, 430 (1994).

    Google Scholar 

  17. Slifkin, R. F., Goldberg, J., Neff, M. S., Baez, A., Mattoo, N., Gupta, S. Malignancy in end-stage renal disease.Trans. Amer. Soc. Artif. Intern. Org., 22, 34 (1977).

    Google Scholar 

  18. Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., Nalesnik, M. A., Ho, M., Griffith, B. P., Hakala, T. R., Hardesty, R. L., Jaffe, R.: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.Lancet, 1, 583 (1984).

    Article  PubMed  CAS  Google Scholar 

  19. Swanson, M. A., Schwarz, R. S.: Immunosuppressive therapy: The relation between clinical response and immunologic completence.N. Engl. J. Med., 277, 163 (1967).

    Article  PubMed  CAS  Google Scholar 

  20. Doak, P. B., Montgomerie, J. Z., North, J. D. K., Smith, F.: Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.Br. Med. J., 4, 746 (1968).

    PubMed  CAS  Google Scholar 

  21. Gentile, G., Formelli, G., Orsoni, G., Rinaldi, A. M., Busacchi, P.: Immunosuppression and human genital papilloma virus infection.Eur. J. Gynaecol. Oncol., 12, 79 (1981).

    Google Scholar 

  22. Penn, I.: Incidence and treatment of neoplasia after transplantation.J. Heart Lung Transplant., 12, 328 (1993).

    Google Scholar 

  23. Birkeland, S. A.: Malignant tumors in renal transplant patients. The Scandia transplant material.Cancer, 51, 1571 (1983).

    Article  PubMed  CAS  Google Scholar 

  24. Dyall-Smith, D., Trowell, H., Mark, A., Dyall-Smith, M. L.: Cutaneous squamous cell carcinomas and papilloma viruses in renal transplant recipients: A clinical and molecular biological study.J. Dermatol. Sci., 2, 139 (1991).

    Article  PubMed  CAS  Google Scholar 

  25. Euvrard, S., Chardonnet, Y., Pouteil-Noble, C., Kanitakis, J., Chignol, M. C., Thivolet, J., Touraine, J. L.: Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papilloma viruses in renal transplant recipients.Cancer, 72, 2198 (1993).

    Article  PubMed  CAS  Google Scholar 

  26. Hartevelt, M. M., Bavinck, J. N. B., Kootte, A. M. M., Vermeer, B. J., Vandenbroucke, J. P.: Incidence of skin cancer after renal transplantation in the Netherlands.Transplantation, 49, 506 (1990).

    Article  PubMed  CAS  Google Scholar 

  27. Strumina, R., Perini, L., Tarroni, G., Fiocchi, O., Gilli, P.: Skin lesions in kidney transplant recipients.Nephron, 62, 137 (1992).

    Article  Google Scholar 

  28. Penn, I.: Secondary neoplasms as a consequence of transplantation and cancer therapy.Cancer Detect. Prevent., 12, 39 (1988).

    PubMed  CAS  Google Scholar 

  29. Gitsch, G., Kainz, C., Pohanka, E., Reinthaller, A., Kovarik, J., Tatra, G., Breitenecker, G.: Humane Papillomavirus-Infektion der Cervix uteri bei immunsupprimierten Frauen nach Nierentransplantation.Geburtshilfe Frauenheilkd., 52, 764 (1992).

    PubMed  CAS  Google Scholar 

  30. Ishikawa, I., Saito, Y., Onouchi, Z., Kitada, H., Suzuki, S., Kurihara, S. Yuri, T., Shinoda, A.: Development of acquired cystic disease and adenocarcinoma of the kidney in glomerulonephritic chronic hemodialysis patients.Clin. Nephrol., 14, 1 (1980).

    PubMed  CAS  Google Scholar 

  31. Sheil, A. G. R., Flavel, S., Disney, A. P. S., Mathew, T. H.: Cancer development in patients progressing to dialysis and renal transplantation.Transplant. Proc., 17, 1685 (1985).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winter, P., Schoeneich, G., Miersch, W.D.E. et al. Tumour induction as a consequence of immunosuppression after renal transplantation. International Urology and Nephrology 29, 701–709 (1997). https://doi.org/10.1007/BF02552189

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02552189

Keywords

Navigation